Can breast cancer drugs speed up aging? new study investigates
NCT ID NCT05700006
First seen Mar 17, 2026 · Last updated Jun 24, 2026 · Updated 16 times
Summary
This observational study enrolled 94 women with breast cancer to see if it's possible to collect blood, stool, and survey data from older patients taking aromatase inhibitors (a type of hormone therapy). The main goal was to test the feasibility of gathering this information for future research on how these drugs might affect aging. Participants provided samples and answered questionnaires over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGING are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan, 48109, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
aromatase inhibitor (anastrozole, exemestane, or letrozole)
What this could lead to
If successful, this study could help design larger trials that clarify how hormone therapy affects aging in older breast cancer survivors.
What could go wrong
This is a small pilot study focused on feasibility, not on proving any effects on aging. Results may not lead to changes in treatment.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.